Klein F A, Herr H W, Whitmore W F, Pinsky C H, Oettgen H T, Melamed M R
Urology. 1981 Apr;17(4):310-4. doi: 10.1016/0090-4295(81)90252-1.
The automated flow cytometry system (FCM) at Memorial Sloan-Kettering Cancer Center has been used to monitor the effect of intravesical BCG in the therapy of superficial bladder cancer. Analysis of saline bladder washings prior to therapy, weekly during the six weeks of therapy, and at follow-up examination in 2 patients, 1 responder and 1 nonresponder, provides the basis for some projections regarding the potential value of this technique.
纪念斯隆凯特琳癌症中心的自动流式细胞仪系统(FCM)已用于监测膀胱内卡介苗在浅表性膀胱癌治疗中的效果。对2例患者(1例有反应者和1例无反应者)在治疗前、治疗六周期间每周以及随访检查时的膀胱冲洗盐水进行分析,为有关该技术潜在价值的一些预测提供了依据。